Sign in Pull a receipt

LGND

LIGAND PHARMACEUTICALS INC

Healthcare · Biotechnology

$172.93 sample

-0.08 (-0.05%) 1D

Market cap

$573.8B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-06

Alerts

8

Price$172.93 +10.83% 3M daily closessample

173.01155.35

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 23INSInsider buy: Chief Executive Officer
Oct 20INSInsider sell: Chief Executive Officer
Oct 13INSInsider sell: 10% owner
Oct 06SEC8-K filed: material event
Oct 01INSInsider buy: 10% owner
Sep 24SEC8-K filed: material event
Sep 17INSInsider sell: 10% owner
Sep 11INSInsider buy: General Counsel

Sign up to see the real LGND record →

Company facts

SEC EDGAR registration

Name: LIGAND PHARMACEUTICALS INC
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -37sample, -100 to +100
Reporting currency: USD

Who is positioning in LGND

sample

Insiders: 16 insider transactions over 90 days, net selling, $456.5M
Congress: 4 members traded over 90 days
Institutions · 13F: 36 funds hold $7.3B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$21.4B +24.3% y/y

Q4 2024Q3 2026

Inventory$12.5B +8.7% y/y

Q4 2024Q3 2026

Accounts receivable$9.5B +11.7% y/y

Q4 2024Q3 2026

Total debt$23.7B +9.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $282.5B +10.7% 3M
Sample peer B: $442.8B +14.9% 3M
Sample peer C: $349.7B +1.3% 3M
Sample peer D: $120.1B +16.3% 3M
Sample peer E: $91.9B +9.8% 3M